169 related articles for article (PubMed ID: 1395956)
21. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
Vrijmoeth P; Heijtink RA; Schreuder H; Kroes AC
Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1694-7. PubMed ID: 9543786
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
Xu H; Zuo H; Zhuang G
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
[TBL] [Abstract][Full Text] [Related]
23. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
24. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
26. [Long-term efficacy study of hepatitis B vaccination in newborns--results of 11 years' follow-up].
Lin X; Xu Z; Ou-Yang P
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Jun; 20(3):174-7. PubMed ID: 10682531
[TBL] [Abstract][Full Text] [Related]
27. [A study on the relationship between maximal titers of anti-HBs antibodies and persistence of protective level after vaccination].
Li SQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):134-7. PubMed ID: 1423534
[TBL] [Abstract][Full Text] [Related]
28. [A study on the effectiveness of hepatitis B vaccine among the vaccinated population].
Wang C; Li D
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):43-6. PubMed ID: 10322708
[TBL] [Abstract][Full Text] [Related]
29. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
30. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
31. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
[TBL] [Abstract][Full Text] [Related]
32. Cost-benefit analysis of hepatitis B vaccination.
Jönsson B
Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
34. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
Mulley AG; Silverstein MD; Dienstag JL
N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
[TBL] [Abstract][Full Text] [Related]
35. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
36. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
37. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
38. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
[TBL] [Abstract][Full Text] [Related]
40. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
Chen H; Zhu QR
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
